Extravascular Implantable Cardioverter-Defibrillators in Children: Real World Evidence

The extravascular implantable cardioverter-defibrillator (EV-ICD) is a novel substernal ICD with limited reports in children and adolescents. Single-centre review of EV-ICDs in children <18-years. Clinical, peri-procedural, and electrocardiographic data reviewed, including device performance in routine exercise stress testing. Median follow-up 10.9 (IQR 7.5 – 12.5) months. Between April 2025-April 2026, 15 EV-ICDs were successfully implanted by a single cardiothoracic surgeon: median age 13.8-years, IQR 10.2–16.4; 11 (73%) male; weight 52 kg, IQR 38.2–64.1; BSA 1.6 m 2 , IQR 1.2–1.8. Smallest child was 4-years, 17.3 kg (BSA 0.7 m 2 ). Indications were primary ( n = 10) and secondary ( n = 5) prevention. Underlying diagnoses included cardiomyopathy ( n = 9), channelopathy ( n = 3). One child had a previous sternotomy and another severe chest-wall deformity. Median anaesthetic time was 148 min (IQR 130–161), surgical time 68 min (59–88), fluoroscopy time 2.6 min (2.2–3.8). Median 3 (IQR 2–4) day hospitalisation. Two children experienced early complications. In one child, defibrillator threshold testing terminated ventricular fibrillation (VF) into ventricular tachycardia (VT) requiring CPR and a decision to use external cardioversion. The child fully recovered. One adolescent experienced profound bradycardia and syncope early post anaesthesia. R-wave amplitude at implant (5mV, IQR 4.2 – 6.7), discharge (5, IQR 2.8 – 8.1) and latest follow-up (5.8, IQR 3.2 – 13.7) was stable. Device sensing during routine exercise stress testing has been appropriate. There has been one successful appropriate high voltage therapy and no inappropriate high voltage therapy. This is the largest single-centre series internationally, demonstrating reliable paediatric EV-ICD implantation and short-term device performance. Ongoing paediatric surveillance is necessary.

Authors

Institutions

Publication Details

Journal
Pediatric Cardiology
Published
2026-11-21
DOI
https://doi.org/10.1007/s00246-026-04553-0
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Extravascular Implantable Cardioverter-Defibrillators in Children: Real World Evidence

Claire Margaret Lawley, Hiroko Asakai, Julian G. Ayer, Jacqueline Nguyen Khuong et al.
Pediatric Cardiology
Cardiac pacing and defibrillation studies
article

Extravascular Implantable Cardioverter-Defibrillators in Children: Real World Evidence

Claire Margaret Lawley, Hiroko Asakai, Julian G. Ayer, Jacqueline Nguyen Khuong, Jack C. Luxford, David Manning, Christian Turner, Matthew H.L. Liava'a
article en

Abstract

The extravascular implantable cardioverter-defibrillator (EV-ICD) is a novel substernal ICD with limited reports in children and adolescents. Single-centre review of EV-ICDs in children <18-years. Clinical, peri-procedural, and electrocardiographic data reviewed, including device performance in routine exercise stress testing. Median follow-up 10.9 (IQR 7.5 – 12.5) months. Between April 2025-April 2026, 15 EV-ICDs were successfully implanted by a single cardiothoracic surgeon: median age 13.8-years, IQR 10.2–16.4; 11 (73%) male; weight 52 kg, IQR 38.2–64.1; BSA 1.6 m 2 , IQR 1.2–1.8. Smallest child was 4-years, 17.3 kg (BSA 0.7 m 2 ). Indications were primary ( n = 10) and secondary ( n = 5) prevention. Underlying diagnoses included cardiomyopathy ( n = 9), channelopathy ( n = 3). One child had a previous sternotomy and another severe chest-wall deformity. Median anaesthetic time was 148 min (IQR 130–161), surgical time 68 min (59–88), fluoroscopy time 2.6 min (2.2–3.8). Median 3 (IQR 2–4) day hospitalisation. Two children experienced early complications. In one child, defibrillator threshold testing terminated ventricular fibrillation (VF) into ventricular tachycardia (VT) requiring CPR and a decision to use external cardioversion. The child fully recovered. One adolescent experienced profound bradycardia and syncope early post anaesthesia. R-wave amplitude at implant (5mV, IQR 4.2 – 6.7), discharge (5, IQR 2.8 – 8.1) and latest follow-up (5.8, IQR 3.2 – 13.7) was stable. Device sensing during routine exercise stress testing has been appropriate. There has been one successful appropriate high voltage therapy and no inappropriate high voltage therapy. This is the largest single-centre series internationally, demonstrating reliable paediatric EV-ICD implantation and short-term device performance. Ongoing paediatric surveillance is necessary.

Pediatric Cardiology
The University of Sydney (AU), New South Wales Department of Health (AU), Children's Hospital at Westmead (AU), Westmead Hospital (AU)
Cardiac pacing and defibrillation studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon